| 227.72 Delayed Data As of Oct 16 |  +1.66 / +0.73%Today’s Change | 215.78 Today|||52-Week Range 344.00 | -24.33% Year-to-Date |
| Why Did the Market Whack This IPO? Oct 14 / MotleyFool.com - Paid Partner Content | Biogen's Two MS Drugs Get CHMP Nod for Use in Pregnancy Sep 24 / Zacks.com - Paid Partner Content |
| Better Buy: Biogen vs. Gilead Sciences Oct 10 / MotleyFool.com - Paid Partner Content | Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Sep 20 / Zacks.com - Paid Partner Content |
| A Biotech Set to Dominate the Next 20 Years Oct 01 / MotleyFool.com - Paid Partner Content | Biogen's New Study to Test Higher Dose of SMA Drug Spinraza Sep 19 / Zacks.com - Paid Partner Content |
| 2 Biotechs Tackling the Challenge of Lou Gehrig’s Disease Sep 30 / MotleyFool.com - Paid Partner Content | Alexion (ALXN) Down on News of CFO Clancy's Departure in 2019 Sep 19 / Zacks.com - Paid Partner Content |
| Better Buy: Biogen vs. Amgen Sep 27 / MotleyFool.com - Paid Partner Content | Biotech Stock Roundup: BIIB Halts AD Study, AMGN Posts Positive MM Drug Data & More Sep 18 / Zacks.com - Paid Partner Content |
| Previous close | 226.06 |
| Today’s open | 226.23 |
| Day’s range | 225.96 - 229.75 |
| Volume | 1,380,284 |
| Average volume (3 months) | 1,522,992 |
| Market cap | $41.2B |
| Earnings growth (last year) | +81.10% |
| Earnings growth (this year) | +23.04% |
| Earnings growth (next 5 years) | +2.68% |
| Revenue growth (last year) | +9.67% |
| P/E ratio | 8.5 |
| Price/Sales | 5.13 |
| Price/Book | 3.38 |
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | -2.50 | -0.80% |
| EXASExact Sciences Corp | -2.16 | -2.17% |
| BMRNBiomarin Pharmaceuti... | -0.57 | -0.83% |
| NBIXNeurocrine Bioscienc... | +0.26 | +0.28% |
| Next reporting date | October 22, 2019 |
| EPS forecast (this quarter) | $8.28 |
| Annual revenue (last year) | $12.1B |
| Annual profit (last year) | $4.4B |
| Net profit margin | 36.76% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
